Liu, J., Li, Q., Wang, Z., Huang, J., Tang, W., Wang, W., Gu, Y., Wei, C., Jin, J., Meng, J., Zhong, S., Wang, X., Hu, W., Hu, B., Wan, X. (2025). An open-label phase 1 dose-escalation and dose-expansion trial to evaluate the safety, tolerability, and efficacy of TQ-B3234 in adults with neurofibromatosis type 1 (NF1).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.3108